Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by ledrogon Jun 11, 2018 8:31pm
186 Views
Post# 28157336

RE:giv a rest gac!!

RE:giv a rest gac!!LoL....I'm not short, never have been....not on RVX or any other stock.  I highly doubt someone caught short would be expressing bullish opinions about RVX trading at $10 by the end of the year....or potentially for $100+ in the years to come.

That's called being bullish on steroids.

We know that as of May 31st stockwatch reported a total of about 1.6 million shares that are short....and expecting a bear attack at some point to defend that position is something I consider prudent.  And it has the nice bonus of tempering my expectations....

I did think an attack was in the cards that would send us down big, maybe even to $1.10.....and I still view that as very possible.  The next short update will be out next week.....we'll see where we are when that comes out.
Bullboard Posts